Yes and AVMD is a buy now. People dont seem to realize that they did $10 million in revenues in England alone and have only been operating there for a little over a year. The company is only being priced at $7 million right now. So one could argue that the stock is undervalued based on its operations in England alone. Australian operations arent even being priced into the stock at this level. Apparently some dont understand what market cap means and how it is typically related to revenues.